Halogenated hydrocarbon general anesthetics refer to hydrocarbon compounds containing halogens and are used for general anesthesia. These anesthetics enter the body by inhalation or intravenous injection, act in the central nervous system, inhibit nerve conduction, and thus cause general anesthesia with loss of consciousness and sensation.
The global Halogenated Hydrocarbon General Anesthetics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Halogenated Hydrocarbon General Anesthetics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Halogenated Hydrocarbon General Anesthetics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Halogenated Hydrocarbon General Anesthetics include Hebei Yipin Pharmaceutical Co., Ltd., Shanghai Hengrui Medicine Co., Ltd., Hebei Sams Pharmaceutical Co., Ltd., Fujian Haixi United Pharmaceutical Co., Ltd., Shandong New Era Pharmaceutical Co., Ltd., Sichuan Baili Pharmaceutical Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd., Piramal Critical Care, AbbVie, Baxter, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Halogenated Hydrocarbon General Anesthetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Halogenated Hydrocarbon General Anesthetics.
The Halogenated Hydrocarbon General Anesthetics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Halogenated Hydrocarbon General Anesthetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Halogenated Hydrocarbon General Anesthetics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hebei Yipin Pharmaceutical Co., Ltd.
Shanghai Hengrui Medicine Co., Ltd.
Hebei Sams Pharmaceutical Co., Ltd.
Fujian Haixi United Pharmaceutical Co., Ltd.
Shandong New Era Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Lunan Beite Pharmaceutical Co., Ltd.
Piramal Critical Care
AbbVie
Baxter
Halocarbon
Segment by Type
Enflurane
Desflurane
Sevoflurane
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Halogenated Hydrocarbon General Anesthetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Halogenated Hydrocarbon General Anesthetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Halogenated Hydrocarbon General Anesthetics 麻豆原创 Overview
1.1 Product Definition
1.2 Halogenated Hydrocarbon General Anesthetics by Type
1.2.1 Global Halogenated Hydrocarbon General Anesthetics 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Enflurane
1.2.3 Desflurane
1.2.4 Sevoflurane
1.3 Halogenated Hydrocarbon General Anesthetics by Application
1.3.1 Global Halogenated Hydrocarbon General Anesthetics 麻豆原创 Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Halogenated Hydrocarbon General Anesthetics 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Halogenated Hydrocarbon General Anesthetics Revenue 2019-2030
1.4.2 Global Halogenated Hydrocarbon General Anesthetics Sales 2019-2030
1.4.3 Global Halogenated Hydrocarbon General Anesthetics 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Halogenated Hydrocarbon General Anesthetics 麻豆原创 Competition by Manufacturers
2.1 Global Halogenated Hydrocarbon General Anesthetics Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Halogenated Hydrocarbon General Anesthetics Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Halogenated Hydrocarbon General Anesthetics Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Halogenated Hydrocarbon General Anesthetics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Halogenated Hydrocarbon General Anesthetics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Halogenated Hydrocarbon General Anesthetics, Product Type & Application
2.7 Global Key Manufacturers of Halogenated Hydrocarbon General Anesthetics, Date of Enter into This Industry
2.8 Global Halogenated Hydrocarbon General Anesthetics 麻豆原创 Competitive Situation and Trends
2.8.1 Global Halogenated Hydrocarbon General Anesthetics 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Halogenated Hydrocarbon General Anesthetics Players 麻豆原创 Share by Revenue
2.8.3 Global Halogenated Hydrocarbon General Anesthetics 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Halogenated Hydrocarbon General Anesthetics 麻豆原创 Scenario by Region
3.1 Global Halogenated Hydrocarbon General Anesthetics 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Region: 2019-2030
3.2.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Region: 2019-2024
3.2.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Region: 2025-2030
3.3 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region: 2019-2030
3.3.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region: 2019-2024
3.3.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region: 2025-2030
3.4 North America Halogenated Hydrocarbon General Anesthetics 麻豆原创 Facts & Figures by Country
3.4.1 North America Halogenated Hydrocarbon General Anesthetics 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Halogenated Hydrocarbon General Anesthetics Sales by Country (2019-2030)
3.4.3 North America Halogenated Hydrocarbon General Anesthetics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Halogenated Hydrocarbon General Anesthetics 麻豆原创 Facts & Figures by Country
3.5.1 Europe Halogenated Hydrocarbon General Anesthetics 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Halogenated Hydrocarbon General Anesthetics Sales by Country (2019-2030)
3.5.3 Europe Halogenated Hydrocarbon General Anesthetics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Halogenated Hydrocarbon General Anesthetics 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Halogenated Hydrocarbon General Anesthetics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales by Region (2019-2030)
3.6.3 Asia Pacific Halogenated Hydrocarbon General Anesthetics Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Halogenated Hydrocarbon General Anesthetics 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Halogenated Hydrocarbon General Anesthetics 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Halogenated Hydrocarbon General Anesthetics Sales by Country (2019-2030)
3.7.3 Latin America Halogenated Hydrocarbon General Anesthetics Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Halogenated Hydrocarbon General Anesthetics 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Halogenated Hydrocarbon General Anesthetics 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2019-2030)
4.1.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2019-2024)
4.1.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2025-2030)
4.1.3 Global Halogenated Hydrocarbon General Anesthetics Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2019-2030)
4.2.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2019-2024)
4.2.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2025-2030)
4.2.3 Global Halogenated Hydrocarbon General Anesthetics Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Halogenated Hydrocarbon General Anesthetics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2019-2030)
5.1.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2019-2024)
5.1.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2025-2030)
5.1.3 Global Halogenated Hydrocarbon General Anesthetics Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2019-2030)
5.2.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2019-2024)
5.2.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2025-2030)
5.2.3 Global Halogenated Hydrocarbon General Anesthetics Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Halogenated Hydrocarbon General Anesthetics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hebei Yipin Pharmaceutical Co., Ltd.
6.1.1 Hebei Yipin Pharmaceutical Co., Ltd. Company Information
6.1.2 Hebei Yipin Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.1.5 Hebei Yipin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Shanghai Hengrui Medicine Co., Ltd.
6.2.1 Shanghai Hengrui Medicine Co., Ltd. Company Information
6.2.2 Shanghai Hengrui Medicine Co., Ltd. Description and Business Overview
6.2.3 Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.2.5 Shanghai Hengrui Medicine Co., Ltd. Recent Developments/Updates
6.3 Hebei Sams Pharmaceutical Co., Ltd.
6.3.1 Hebei Sams Pharmaceutical Co., Ltd. Company Information
6.3.2 Hebei Sams Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.3.5 Hebei Sams Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Fujian Haixi United Pharmaceutical Co., Ltd.
6.4.1 Fujian Haixi United Pharmaceutical Co., Ltd. Company Information
6.4.2 Fujian Haixi United Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.4.5 Fujian Haixi United Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Shandong New Era Pharmaceutical Co., Ltd.
6.5.1 Shandong New Era Pharmaceutical Co., Ltd. Company Information
6.5.2 Shandong New Era Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.5.5 Shandong New Era Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Sichuan Baili Pharmaceutical Co., Ltd.
6.6.1 Sichuan Baili Pharmaceutical Co., Ltd. Company Information
6.6.2 Sichuan Baili Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.6.5 Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Lunan Beite Pharmaceutical Co., Ltd.
6.7.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
6.7.2 Lunan Beite Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.7.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Piramal Critical Care
6.8.1 Piramal Critical Care Company Information
6.8.2 Piramal Critical Care Description and Business Overview
6.8.3 Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.8.5 Piramal Critical Care Recent Developments/Updates
6.9 AbbVie
6.9.1 AbbVie Company Information
6.9.2 AbbVie Description and Business Overview
6.9.3 AbbVie Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AbbVie Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.9.5 AbbVie Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Company Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Baxter Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 Halocarbon
6.11.1 Halocarbon Company Information
6.11.2 Halocarbon Description and Business Overview
6.11.3 Halocarbon Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Halocarbon Halogenated Hydrocarbon General Anesthetics Product Portfolio
6.11.5 Halocarbon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Halogenated Hydrocarbon General Anesthetics Industry Chain Analysis
7.2 Halogenated Hydrocarbon General Anesthetics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Halogenated Hydrocarbon General Anesthetics Production Mode & Process
7.4 Halogenated Hydrocarbon General Anesthetics Sales and 麻豆原创ing
7.4.1 Halogenated Hydrocarbon General Anesthetics Sales Channels
7.4.2 Halogenated Hydrocarbon General Anesthetics Distributors
7.5 Halogenated Hydrocarbon General Anesthetics Customers
8 Halogenated Hydrocarbon General Anesthetics 麻豆原创 Dynamics
8.1 Halogenated Hydrocarbon General Anesthetics Industry Trends
8.2 Halogenated Hydrocarbon General Anesthetics 麻豆原创 Drivers
8.3 Halogenated Hydrocarbon General Anesthetics 麻豆原创 Challenges
8.4 Halogenated Hydrocarbon General Anesthetics 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Hebei Yipin Pharmaceutical Co., Ltd.
Shanghai Hengrui Medicine Co., Ltd.
Hebei Sams Pharmaceutical Co., Ltd.
Fujian Haixi United Pharmaceutical Co., Ltd.
Shandong New Era Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Lunan Beite Pharmaceutical Co., Ltd.
Piramal Critical Care
AbbVie
Baxter
Halocarbon
听
听
*If Applicable.